New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology

Abstract Until recently the application of artificial intelligence (AI) in precision oncology was confined to activities in drug development and had limited impact on the personalisation of therapy. Now, a number of approaches have been proposed for the personalisation of drug and cell therapies wit... View More